Nagoya, Japan

Takahiko Matani

This inventor holds 1 USPTO granted patent. Top assignee: Sanwa Kagaku Kenkyusho Co., Ltd.. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takahiko Matani. Retrieved from https://idiyas.com/inventor/takahiko-matani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Takahiko Matani: Innovator in Polypeptide Research

Introduction

Takahiko Matani is a notable inventor based in Nagoya, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides. His work has implications for various applications in medicine and research.

Latest Patents

Takahiko Matani holds a patent for a "Motilin-like polypeptide and use thereof." This patent describes a process for the preparation of a polypeptide with a specific formula, which includes various amino acid residues. The invention also encompasses a recombinant DNA and expression plasmid for preparing the polypeptide, showcasing his innovative approach to biotechnology.

Career Highlights

Throughout his career, Matani has been associated with Sanwa Kagaku Kenkyusho Co., Ltd., where he has furthered his research and development efforts. His work has led to advancements in the understanding and application of polypeptides in various scientific fields.

Collaborations

Takahiko Matani has collaborated with esteemed colleagues such as Masayasu Kurono and Haruo Takahashi. These partnerships have contributed to the success of his research endeavors and the advancement of their shared goals in biotechnology.

Conclusion

Takahiko Matani's contributions to the field of polypeptide research highlight his innovative spirit and dedication to scientific advancement. His patent and collaborations reflect his commitment to pushing the boundaries of biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…